S&P 500   5,251.59 (+0.06%)
DOW   39,764.85 (+0.01%)
QQQ   444.25 (-0.13%)
AAPL   171.20 (-1.22%)
MSFT   419.89 (-0.37%)
META   486.02 (-1.59%)
GOOGL   150.66 (-0.14%)
AMZN   179.92 (+0.05%)
TSLA   177.64 (-1.22%)
NVDA   907.63 (+0.57%)
NIO   4.61 (-1.28%)
AMD   182.03 (+1.36%)
BABA   72.47 (+1.23%)
T   17.61 (+0.34%)
F   13.21 (+1.15%)
MU   118.10 (-0.87%)
CGC   9.78 (+2.41%)
GE   175.38 (-2.63%)
DIS   122.58 (+1.32%)
AMC   3.70 (-14.75%)
PFE   27.91 (+0.47%)
PYPL   67.53 (+1.44%)
XOM   115.75 (+0.68%)
S&P 500   5,251.59 (+0.06%)
DOW   39,764.85 (+0.01%)
QQQ   444.25 (-0.13%)
AAPL   171.20 (-1.22%)
MSFT   419.89 (-0.37%)
META   486.02 (-1.59%)
GOOGL   150.66 (-0.14%)
AMZN   179.92 (+0.05%)
TSLA   177.64 (-1.22%)
NVDA   907.63 (+0.57%)
NIO   4.61 (-1.28%)
AMD   182.03 (+1.36%)
BABA   72.47 (+1.23%)
T   17.61 (+0.34%)
F   13.21 (+1.15%)
MU   118.10 (-0.87%)
CGC   9.78 (+2.41%)
GE   175.38 (-2.63%)
DIS   122.58 (+1.32%)
AMC   3.70 (-14.75%)
PFE   27.91 (+0.47%)
PYPL   67.53 (+1.44%)
XOM   115.75 (+0.68%)
S&P 500   5,251.59 (+0.06%)
DOW   39,764.85 (+0.01%)
QQQ   444.25 (-0.13%)
AAPL   171.20 (-1.22%)
MSFT   419.89 (-0.37%)
META   486.02 (-1.59%)
GOOGL   150.66 (-0.14%)
AMZN   179.92 (+0.05%)
TSLA   177.64 (-1.22%)
NVDA   907.63 (+0.57%)
NIO   4.61 (-1.28%)
AMD   182.03 (+1.36%)
BABA   72.47 (+1.23%)
T   17.61 (+0.34%)
F   13.21 (+1.15%)
MU   118.10 (-0.87%)
CGC   9.78 (+2.41%)
GE   175.38 (-2.63%)
DIS   122.58 (+1.32%)
AMC   3.70 (-14.75%)
PFE   27.91 (+0.47%)
PYPL   67.53 (+1.44%)
XOM   115.75 (+0.68%)
S&P 500   5,251.59 (+0.06%)
DOW   39,764.85 (+0.01%)
QQQ   444.25 (-0.13%)
AAPL   171.20 (-1.22%)
MSFT   419.89 (-0.37%)
META   486.02 (-1.59%)
GOOGL   150.66 (-0.14%)
AMZN   179.92 (+0.05%)
TSLA   177.64 (-1.22%)
NVDA   907.63 (+0.57%)
NIO   4.61 (-1.28%)
AMD   182.03 (+1.36%)
BABA   72.47 (+1.23%)
T   17.61 (+0.34%)
F   13.21 (+1.15%)
MU   118.10 (-0.87%)
CGC   9.78 (+2.41%)
GE   175.38 (-2.63%)
DIS   122.58 (+1.32%)
AMC   3.70 (-14.75%)
PFE   27.91 (+0.47%)
PYPL   67.53 (+1.44%)
XOM   115.75 (+0.68%)
NYSE:CCM

Concord Medical Services (CCM) Stock Price, News & Analysis

$0.60
+0.01 (+2.18%)
(As of 12:08 PM ET)
Today's Range
$0.55
$0.61
50-Day Range
$0.40
$1.09
52-Week Range
$0.38
$1.60
Volume
5,941 shs
Average Volume
9,402 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CCM stock logo

About Concord Medical Services Stock (NYSE:CCM)

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, head gamma knife system, and diagnostic imaging services. The company's other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

CCM Stock Price History

CCM Stock News Headlines

Concord Medical Services Holdings Ltd. ADR
Concord Medical Services Holdings Ltd (C2CA.SG)
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Concord Place (formly Avenir of Knoxville)
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Concord Medical Services (NYSE: CCM)
Free clinic in Concord to undergo major renovations
Concord Medical Files 2022 Annual Report on Form 20-F
Concorde Career Colleges, Inc.
See More Headlines
Receive CCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Concord Medical Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/24/2016
Today
3/28/2024
Next Earnings (Estimated)
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Employees
918
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.45 million
Book Value
$6.73 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.21
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Jianyu Yang (Age 53)
    Chairman & CEO
  • Mr. Boxun Zhang (Age 48)
    Chief Financial Officer
  • Ms. Xun Liu
    Financial Controller

CCM Stock Analysis - Frequently Asked Questions

How have CCM shares performed in 2024?

Concord Medical Services' stock was trading at $1.10 at the start of the year. Since then, CCM shares have decreased by 45.5% and is now trading at $0.5999.
View the best growth stocks for 2024 here
.

Are investors shorting Concord Medical Services?

Concord Medical Services saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 7,000 shares, an increase of 218.2% from the February 29th total of 2,200 shares. Based on an average daily volume of 7,600 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.0% of the shares of the company are sold short.
View Concord Medical Services' Short Interest
.

When is Concord Medical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 17th 2024.
View our CCM earnings forecast
.

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Holdings Limited (NYSE:CCM) issued its earnings results on Wednesday, August, 24th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by $0.27. The business earned $18.93 million during the quarter.

What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Concord Medical Services investors own include The Carlyle Group (CG), (HCLP) (HCLP), Fibrocell Science (FCSC), Gilead Sciences (GILD), Laurentian Bank of Canada (LB), Altria Group (MO), Domtar (UFS), Arbutus Biopharma (ABUS), Franklin Resources (BEN) and Biocept (BIOC).

Who are Concord Medical Services' major shareholders?

Concord Medical Services' stock is owned by a number of retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Concord Medical Services?

Shares of CCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CCM) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners